...
首页> 外文期刊>Alimentary pharmacology & therapeutics. >Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China
【24h】

Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China

机译:评论文章:原发性布加综合征的病因-中西差异

获取原文
获取原文并翻译 | 示例

摘要

BackgroundChina may have the largest number of Budd-Chiari syndrome (BCS) cases in the world (at least 1914 original papers were published, and at least 20 191 BCS patients were reported). Considering the discrepancy in the clinical profiles and preferred treatment selection of primary BCS between the West and China, understanding its aetiology in these two different regions is very important.
机译:背景中国可能是世界上Budd-Chiari综合征(BCS)病例最多的国家(至少发表了1914篇原始论文,并报告了至少20 191例BCS患者)。考虑到中西部地区原发性BCS的临床特征和首选治疗选择存在差异,了解这两个地区的病因非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号